Articles by Keyword for

Congress is considering relaxing FDA rules on drug conflicts of interest. The FDA has taken the position that it is very difficult to recruit highly qualified people onto committees that determine whether or not a drug will be approved by the FDA. They say that 23% of FDA Advisory Panels have vacancies and that people who are the most knowledgeable should be...